University Of Notre Dame Du Lac Neurocrine Biosciences Inc Transaction History

University Of Notre Dame Du Lac

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $895,742 - $1.37 Million	-10,527 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $137,376 - $208,067	1,829 Added 21.03%	10,527 $911,000
Q4 2019 Feb 14, 2020	SELL	$86.8 - $118.57 $59,458 - $81,220	-685 Reduced 7.3%	8,698 $935,000
Q3 2019 Nov 13, 2019	SELL	$83.82 - $101.5 $3.09 Million - $3.75 Million	-36,907 Reduced 79.73%	9,383 $846,000
Q2 2019 Aug 14, 2019	BUY	$72.24 - $91.27 $3.34 Million - $4.22 Million	46,290 New	46,290 $3.91 Million

625

95.2M

661K

227K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

Stay updated on University Of Notre Dame Du Lac with notifications on news.